Stem Cell Review: Looking Forward to 2015
Quick Links
Description
You are Watching:
Stem Cell Review: Looking Forward to 2015
How will stem cells change the way we think about treating diseases? Here is the 5 year forward look at the world of Stem Cells, from some of the greatest experts in the field.
What are the diseases we'll be treating, and the tools we'll be using in 2015? Where will we be in terms of clinical trials? What are the dangers in the stem cell hype, and medical tourism? How will stem cells pave the way for personalized medicine, and more rational treatments? How important will stem cells become in the drug discovery process? Discussed in the episode are the eye (macular degeneration), the skin, diabetes (type 1 & 2), blood and autoimmune diseases, glioblastoma, HIV, and more.
This is the Episode 5 of the Stem Cell Review, aired on October 29nd, 2009
Related Videos
Stem Cell Review: Tools for Drug Screening (EP4) (16:13)
<all>Researchers are using stem cells as tools for disease study, drug screening, clinical trial strategy, and personalized medicine. The induced Pluripotent Stem cell (iPS) is giving us a chance to rethink the way we are developing new drugs. These iPS cells are usually created from somatic cells (such as skin), and not embryos or adult stem cells. In creating iPS from patients' diseased cells, scientists can study the disease in vitro, looking for disease phenotypes, applying microenvironmental stress, and testing new drugs. Compared to animal model testing (e.g. mice), this represents a significant breakthrough, that can be used to validate clinical development strategy and test efficacy in specific groups of patients. iPS is bringing a revolution in drug discovery methodology which is being used to bridge genetics, cell biology, and physiology.
Stem Cell Review: Biological Processes & Industrial Production (EP3) (22:49)
<all>What are the biological processes that stem cells go through? What are the industrial processes we need to manufacturing? What do we know about cancer stem cells? How do iPS cells fit into the picture vs. embryonic stem cells? In this episode we investigate how the science and research of stem cells is being translated into industrial cell processes to create FDA approvable, and commercializable products. Differentiation, proliferation, migration, retro-differentiation, trans-differentiation, transformation into cancer cells, the role of tumors' micro environments and epigenetics and all reviewed here by the field's foremost experts.
Stem Cell Review: Biological Processes & Industrial Productio...
Stem Cell Review: Allogeneic or Autologous? (EP2) (24:56)
<all>Reviewing the technology, business models, intellectual property, regulatory concerns, transplantation and immune rejection. This is the 2nd episode of the Stem Cell Review.
Stem Cell Review: Stem Cells at a Glance (EP1) (18:37)
<all>What are the different types of stem cells? Potential medical applications? Different business models? Ethical and political constraints? This 1st episode of the Stem Cell Review is a good introductory overview of stem cells.
Credits
In Order of Appearance:
GUESTS
George Q. Daley, M.D., Ph.D. - Harvard Medical School // Samuel E. Lux, IV Chair in Hematology, Director, Stem Cell Transplantation Program, Children's Hospital Boston
Dr. Ronald D.G. McKay - NIH Senior Investigator, Laboratory of Molecular Biology, Porter Neuroscience Research Center, NINDS (National Institute of Neurological Disorders and Stroke) - a part of the NIH (National Institutes of Health)
Dan Marshak Ph.D. - PerkinElmer, Inc. // Chief Scientific Officer and President, Greater China
Rudolf Jaenisch, M.D., MIT // Professor of Biology, Whitehead Institute and Dept. of Biology, MIT (Massachusetts Institute of Technology)
John Sinden, Ph.D. - ReNeuron Group // Chief Scientific Officer
Alan O. Trounson, Ph.D. - California Institute for Regenerative Medicine // President
Alan Colman, Ph.D., M.A. - A*STAR Institute of Medical Biology // Executive Director, Singapore Stem Cell Consortium (SSCC); Principal Investigator, Institute of Medical Biology
John Walker - iPierian // Chief Executive Officer
Shinya Yamanaka, M.D., Ph.D. - UCSF and Kyoto University // Senior Investigator, Gladstone Institute of Cardiovascular Disease, L.K. Whittier Foundation Investigator in Stem Cell Biology; Professor of Anatomy, University of California, San Francisco; Director, Center for iPS Cell Research and Application (CiRA), Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University; Professor, Department of Stem Cell Sciences, Institute for Frontier Medical Sciences
Irving L. Weissman, M.D - Stanford University // Director of the Stanford Institute of Stem Cell Biology and Regenerative Medicine; Professor of Pathology and Developmental Biology
David T. Scadden, M.D. - Harvard Medical School // Gerald and Darlene Jordan Professor of Medicine, Harvard University; Co-Chair, Department of Stem Cell and Regenerative Biology, Harvard University; Co-Director, Harvard Stem Cell Institute; Director, MGH Center for Regenerative Medicine; Chief, Hematologic Malignancies, MGH Cancer Center
Gregory A. Bonfiglio - Proteus Venture Partners // Managing Partner
IMAGES
Stem Cell Review Studio Background Pictures provided by the California Institute of Regenerative Medicine
A Special Thanks to:
- Ferghana Partners Group
- ISSCR / The International Society for Stem Cell Research
- Genetics Policy Institute / World Stem Cell Summit
- Hilton Hotels / The Hilton Diagonal Mar in Barcelona
MUSIC
Protest by soundroll Five Tribes by ventilo35
Last but not Least!
- Freya Alugas
- Pat Becker
- Melissa Carpenter
- Ellen Charles
- Meagan Comerford
- Karena Essex
- Elisabet Fabregas
- Mario Fante
- Rocio Fontela
- Liz Freyn
- Don Gibbons
- Raj Kaur
- Paul Laland
- Gemma Llamas
- Jillian McFady
- Mary Lou McKeone
- Didier Montarras
- Mario Oliete
- Jose Maria Ruiz
- Valerie Tucker
- Kristen April Uekermann
- Nancy Witty
- Jessica Yingling
About
Acknowledgements
